Modulation of dopamine-dependent behaviors by the Caenorhabditis elegans Olig homolog HLH-17

Journal of Neuroscience Research

Volumn 89, Issue 10, 2011, Pages 1627-1636

  Felton, Chaquettea M ^a   Johnson, Casonya M ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Basal slowing assay; Dopamine receptor; Egg laying assay; Gustatory plasticity; Immobility assay

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR HLH 17; CAENORHABDITIS ELEGANS PROTEIN; DOPAMINE; DOPAMINE RECEPTOR; MESSENGER RNA; SEROTONIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DOP 1 GENE; DOP 2 GENE; DOP 3 GENE; DOSE RESPONSE; DOWN REGULATION; EGG LAYING; EGL 10 GENE; GENE; GENE EXPRESSION; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR GENE; SIGNAL TRANSDUCTION;

ANIMALS; BEHAVIOR, ANIMAL; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; DOPAMINE; FEMALE; HELIX-LOOP-HELIX MOTIFS; MALE; NEUROGLIA; NEURONS; RECEPTORS, DOPAMINE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 79961209931     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22694     Document Type: Article

References (75)

1. Altun ZF, Hall DH. 2008. Handbook of C. elegans anatomy. In: Wormatlas. doi:10.3908/wormatlas.1.19.
2. Altun ZF, Hall DH. 2009. Nervous system, neuronal support cells. In: Wormatlas. doi:10.3908/wormatlas.1.19.
3. Assadi SM, Yucel M, Pantelis C. 2009. Dopamine modulates neural networks involved in effort-based decision-making. Neurosci Biobehav Rev 33: 383-393.
4. Bastiani C, Mendel J. 2006. Heterotrimeric G proteins in C. elegans. WormBook, p 1-25.
5. Bertolino A, Taurisano P, Pisciotta NM, Blasi G, Fazio L, Romano R, Gelao B, Lo Bianco L, Lozupone M, Di Giorgio A, Caforio G, Sambataro F, Niccoli-Asabella A, Papp A, Ursini G, Sinibaldi L, Popolizio T, Sadee W, Rubini G. 2010. Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS One 5: e9348.
6. Bowton E, Saunders C, Erreger K, Sakrikar D, Matthies HJ, Sen N, Jessen T, Colbran RJ, Caron MG, Javitch JA, Blakely RD, Galli A. 2010. Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci 30: 6048-6057.
7. Bröhl D, Strehle M, Wende H, Hori K, Bormuth I, Nave KA, Muller T, Birchmeier C. 2008. A transcriptional network coordinately determines transmitter and peptidergic fate in the dorsal spinal cord. Dev Biol 322: 381-393.
8. Carlsson A. 2001. A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture. Biosci Rep 21: 691-710.
9. Carvelli L, Blakely RD, DeFelice LJ. 2008. Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc Natl Acad Sci U S A 105: 14192-14197.
10. Chase DL, Koelle MR. 2007. Biogenic amine neurotransmitters in C. elegans. WormBook, p 1-15.
11. Chase DL, Pepper JS, Koelle MR. 2004. Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans. Nat Neurosci 7: 1096-1103.
12. Chen L, Xu M. 2010. Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking. J Neurochem 114: 530-541.
13. Dempsey CM, Mackenzie SM, Gargus A, Blanco G, Sze JY. 2005. Serotonin (5HT), fluoxetine, imipramine and dopamine target distinct 5HT receptor signaling to modulate Caenorhabditis elegans egg-laying behavior. Genetics 169: 1425-1436.
14. Donohoe DR, Phan T, Weeks K, Aamodt EJ, Dwyer DS. 2008. Antipsychotic drugs up-regulate tryptophan hydroxylase in ADF neurons of Caenorhabditis elegans: role of calcium-calmodulin-dependent protein kinase II and transient receptor potential vanilloid channel. J Neurosci Res 86: 2553-2563.
15. Duerr J, Frisby DL, Gaskin J, Duke A, Asermely K, Huddleston D, Eiden LE, Rand JB. 1999. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J Neurosci 26: 619-631.
16. Engleman EA, Rodd ZA, Bell RL, Murphy JM. 2008. The role of 5HT3 receptors in drug abuse and as a target for pharmacotherapy. CNS Neurol Disord Drug Targets 7: 454-467.
17. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. 2004. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27: 107-144.
18. Garcia-Borreguero D, Williams AM. 2010. Dopaminergic augmentation of restless legs syndrome. Sleep Med Rev 14: 339-346.
19. Giles AC, Rankin CH. 2009. Behavioral and genetic characterization of habituation using Caenorhabditis elegans. Neurobiol Learn Mem 92: 139-146.
20. Guiard BP, El Mansari M, Blier P. 2009. Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors. Curr Drug Targets 10: 1069-1084.
21. Hajdu-Cronin YM, Chen WJ, Patikoglou G, Koelle MR, Sternberg PW. 1999. Antagonism between G(o)alpha and G(q)alpha in Caenorhabditis elegans: the RGS protein EAT-16 is necessary for G(o)alpha signaling and regulates G(q)alpha activity. Genes Dev 13: 1780-1793.
22. Hukema RK, Rademakers S, Dekkers MP, Burghoorn J, Jansen G. 2006. Antagonistic sensory cues generate gustatory plasticity in Caenorhabditis elegans. EMBO J 25: 312-322.
23. Hukema RK, Rademakers S, Jansen G. 2008. Gustatory plasticity in C. elegans involves integration of negative cues and NaCl taste mediated by serotonin, dopamine, and glutamate. Learn Mem 15: 829-836.
24. Karakaya S, Kipp M, Beyer C. 2007. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. J Neuroendocrinol 19: 682-690.
25. Keating GL, Rye DB. 2003. Where you least expect it: dopamine in the pons and modulation of sleep and REM-sleep. Sleep 26: 788-789.
26. Kehagia AA, Murray GK, Robbins TW. 2010. Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 20: 199-204.
27. Kindt KS, Quast KB, Giles AC, De S, Hendrey D, Nicastro I, Rankin CH, Schafer WR. 2007. Dopamine mediates context-dependent modulation of sensory plasticity in C. elegans. Neuron 55: 662-676.
28. Knab AM, Lightfoot JT. 2010. Does the difference between physically active and couch potato lie in the dopamine system? Int J Biol Sci 6: 133-150.
29. Koelle MR, Horvitz HR. 1996. EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84: 115-125.
30. Kubrusly RC, Panizzutti R, Gardino PF, Stutz B, Reis RA, Ventura AL, de Mello MC, de Mello FG. 2008. Expression of functional dopaminergic phenotype in purified cultured Muller cells from vertebrate retina. Neurochem Int 53: 63-70.
31. Kumar U, Patel SC. 2007. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain. Brain Res 1131: 187-196.
32. Lee J, Jee C, McIntire SL. 2009. Ethanol preference in C. elegans. Genes Brain Behav 8: 578-585.
33. Lee SK, Pfaff SL. 2003. Synchronization of neurogenesis and motor neuron specification by direct coupling of bHLH and homeodomain transcription factors. Neuron 38: 731-745.
34. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lanca AJ, O'Dowd BF, George SR. 2004. Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279: 35671-35678.
35. Lewis JA, Fleming JT. 1995. Basic culture methods. Methods Cell Biol 48: 3-29.
36. Liu J, Wang F, Huang C, Long LH, Wu WN, Cai F, Wang JH, Ma LQ, Chen JG. 2009. Activation of phosphatidylinositol-linked novel D1 dopamine receptor contributes to the calcium mobilization in cultured rat prefrontal cortical astrocytes. Cell Mol Neurobiol 29: 317-328.
37. Lodge DJ, Grace AA. 2008. Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia. Neurotox Res 14: 97-104.
38. McMiller TL, Johnson CM. 2005. Molecular characterization of HLH-17, a C. elegans bHLH protein required for normal larval development. Gene 356: 1-10.
39. Nass R, Merchant KM, Ryan T. 2008. Caenorhabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need. Mol Interv 8: 284-293.
40. Palmiter RD. 2008. Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice. Ann N Y Acad Sci 1129: 35-46.
41. Park CH, Kang JS, Yoon EH, Shim JW, Suh-Kim H, Lee SH. 2008. Proneural bHLH neurogenin 2 differentially regulates Nurr1-induced dopamine neuron differentiation in rat and mouse neural precursor cells in vitro. FEBS Lett 582: 537-542.
42. Patikoglou GA, Koelle MR. 2002. An N-terminal region of Caenorhabditis elegans RGS proteins EGL-10 and EAT-16 directs inhibition of G(alpha)o vs. G(alpha)q signaling. J Biol Chem 277: 47004-47013.
43. Pletnikov MV. 2009. Inducible and conditional transgenic mouse models of schizophrenia. Prog Brain Res 179: 35-47.
44. Remington G. 2008. Alterations of dopamine and serotonin transmission in schizophrenia. Prog Brain Res 172: 117-140.
45. Rye DB. 2004. The two faces of Eve: dopamine's modulation of wakefulness and sleep. Neurology 63: S2-S7.
46. Samanta J, Kessler JA. 2004. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131: 4131-4142.
47. Sanyal S, Wintle RF, Kindt KS, Nuttley WM, Arvan R, Fitzmaurice P, Bigras E, Merz DC, Hebert TE, van der Kooy D, Schafer WR, Culotti JG, Van Tol HH. 2004. Dopamine modulates the plasticity of mechanosensory responses in Caenorhabditis elegans. EMBO J 23: 473-482.
48. Sawin ER, Ranganathan R, Horvitz HR. 2000. C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron 26: 619-631.
49. Schafer WR. 2004. Addiction research in a simple animal model: the nematode Caenorhabditis elegans. Neuropharmacology 47(Suppl 1): 123-131.
50. Schafer WR. 2005. Egg laying. WormBook, p 1-7.
51. Schafer WR, Kenyon CJ. 1995. A calcium-channel homologue required for adaptation to dopamine and serotonin in Caenorhabditis elegans. Nature 375: 73-78.
52. Schmidt M, Lin S, Pape M, Ernsberger U, Stanke M, Kobayashi K, Howard MJ, Rohrer H. 2009. The bHLH transcription factor Hand2 is essential for the maintenance of noradrenergic properties in differentiated sympathetic neurons. Dev Biol 329: 191-200.
53. Scott L, Aperia A. 2009. Interaction between N-methyl-D-aspartic acid receptors and D1 dopamine receptors: an important mechanism for brain plasticity. Neuroscience 158: 62-66.
54. Steeves TD, Fox SH. 2008. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog Brain Res 172: 495-513.
55. Sugiura M, Fuke S, Suo S, Sasagawa N, Van Tol HH, Ishiura S. 2005. Characterization of a novel D2-like dopamine receptor with a truncated splice variant and a D1-like dopamine receptor unique to invertebrates from Caenorhabditis elegans. J Neurochem 94: 1146-1157.
56. Sulston J, Dew M, Brenner S. 1975. Dopaminergic neurons in the nematode Caenorhabditis elegans. J Comp Neurol 163: 215-226.
57. Suo S, Sasagawa N, Ishiura S. 2002. Identification of a dopamine receptor from Caenorhabditis elegans. Neurosci Lett 319: 13-16.
58. Suo S, Ishiura S, Van Tol HH. 2004. Dopamine receptors in C. elegans. Eur J Pharmacol 500: 159-166.
59. Suo S, Culotti J, Van Tol HH. 2009. Dopamine counteracts octopamine signalling in a neural circuit mediating food response in C. elegans. EMBO J 28: 2437-2448.
60. Thomas MJ, Kalivas PW, Shaham Y. 2008. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 154: 327-342.
61. Tomioka M, Adachi T, Suzuki H, Kunitomo H, Schafer WR, Iino Y. 2006. The insulin/PI3-kinase pathway regulates salt chemotaxis learning in Caenorhabditis elegans. Neuron 51: 613-625.
62. Tripp G, Wickens JR. 2008. Research review: dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD. J Child Psychol Psychiatry 49: 691-704.
63. Ullsperger M. 2010. Genetic association studies of performance monitoring and learning from feedback: the role of dopamine and serotonin. Neurosci Biobehav Rev 34: 649-659.
64. Voglis G, Tavernarakis N. 2008. A synaptic DEG/ENaC ion channel mediates learning in C. elegans by facilitating dopamine signalling. EMBO J 27: 3288-3299.
65. Walker QD, Morris SE, Arrant AE, Nagel JM, Parylak S, Zhou G, Caster JM, Kuhn CM. 2010. Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats. J Pharmacol Exp Ther 335: 124-132.
66. Wang HY, Undie AS, Friedman E. 1995. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol Pharmacol 48: 988-994.
67. Ward A, Walker VJ, Feng Z, Xu XZ. 2009. Cocaine modulates locomotion behavior in C. elegans. PLoS One 4: e5946.
68. Weinshenker D, Garriga G, Thomas JH. 1995. Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans. J Neurosci 15: 6975-6985.
69. Wicks SR, de Vries CJ, van Luenen HG, Plasterk RH. 2000. CHE-3, a cytosolic dynein heavy chain, is required for sensory cilia structure and function in Caenorhabditis elegans. Dev Biol 221: 295-307.
70. Wolf FW, Heberlein U. 2003. Invertebrate models of drug abuse. J Neurobiol 54: 161-178.
71. Wolters E, Lees AJ, Volkmann J, van Laar T, Hovestadt A. 2008. Managing Parkinson's disease with continuous dopaminergic stimulation. CNS Spectr 13: 1-14; quiz 15-16.
72. Yoshimura S, Murray JI, Lu Y, Waterston RH, Shaham S. 2008. mls-2 And vab-3 control glia development, hlh-17/Olig expression and glia-dependent neurite extension in C. elegans. Development 135: 2263-2275.
73. Zhou Q, Anderson DJ. 2002. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109: 61-73.
74. Zhu J, Reith ME. 2008. Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS Neurol Disord Drug Targets 7: 393-409.
75. Zimmerman JE, Naidoo N, Raizen DM, Pack AI. 2008. Conservation of sleep: insights from non-mammalian model systems. Trends Neurosci 31: 371-376.